1. Home
  2. VALN vs YDES Comparison

VALN vs YDES Comparison

Compare VALN & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$6.10

Market Cap

537.8M

Sector

Health Care

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$7.43

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
VALN
YDES
Founded
2012
2013
Country
France
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
537.8M
543.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
VALN
YDES
Price
$6.10
$7.43
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$15.75
N/A
AVG Volume (30 Days)
128.2K
19.2K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.00
N/A
Revenue Next Year
$92.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.43
$5.40
52 Week High
$12.25
$25.00

Technical Indicators

Market Signals
Indicator
VALN
YDES
Relative Strength Index (RSI) 25.51 45.61
Support Level $5.69 N/A
Resistance Level $6.73 $9.11
Average True Range (ATR) 0.38 0.87
MACD -0.33 0.18
Stochastic Oscillator 1.11 60.24

Price Performance

Historical Comparison
VALN
YDES

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: